| Date | Title | Description |
| 18.03.2022 | Ampersand Health – NHSX today at #REWIRED22 announced the la... | Ampersand Health are excited to be working in partnership with St George’s University Hospitals NHS ... |
| 25.02.2022 | Centauri Therapeutics closes £24 million GBP Series A invest... | London, UK, 16 February 2022: Centauri Therapeutics Limited (Centauri), an immunotherapy company fou... |
| 17.11.2021 | Curesponse Secures Additional USD 8 Million Funding for Its ... | REẖOVOT, Israel, November 15, 2021 (Newswire.com) – Curesponse (www.curesponse.com) has secured addi... |
| 12.05.2021 | Sana Health Receives FDA “Breakthrough Device Designation” f... | LAFAYETTE, CO
Sana Health ( http:///www.sana.io ) , a Colorado-based medical technology startup bac... |
| 27.01.2021 | Ampersand Health launches a new digital therapeutic for peop... | 19th January 2021, London: Ampersand Health, experts in digital therapeutics for long-term inflammat... |
| 21.10.2020 | Research by emteq labs reveals how emotion measurement could... | The AI Journal has covered the latest research by portfolio Emteq, acknowledging their current succe... |
| 23.09.2020 | LifeArc and UK government’s Future Fund provide £3.0m in fun... | LifeArc, an independent medical research charity,announces a £3.0m co-investment in British biotech ... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 milli... | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of... |
| 17.09.2020 | Immune system ‘bully boys’ square up to coronavirus crisis... | Scalable, affordable, effective. Read about TC Biopharm’s stunning progress in the Financial Times h... |
| 01.07.2020 | TC BioPharm C-19 Therapy Trials Approved | Porfolio company TC BioPharm has had their T-cell therapy approved for trials in Scotland for Covid-... |
| 11.06.2020 | NCL is UK Lead of $6M Series A for Curesponse | NCL is delighted to welcome Curesponse to our portfolio, a breakthrough cancer precision medicine co... |
| 06.04.2020 | TC BioPharm to begin trialling T-cell therapy against Covid-... | Fantastic to see the Telegraph and the Daily Mail covering the work of TC BioPharm, one of our portf... |
| 17.09.2019 | Award for ALERT at product launch! |
After an absolutely fantastic product launch last week, the team at Alert Technology are slowly co... |
| 13.08.2019 | The child who inspired Andiamo – London’s most exciting tech... | The agony suffered by tragic Diamo Parvez motivated parents Samiya and Naveed to alleviate the suffe... |
| 09.05.2019 | These face-reading glasses track physical and mental health | Surgeon Charles Nduka has developed sensor tech to track facial expressions and is currently using i... |
| 02.04.2019 | New pharma Azadyne raises £1.5m for autoimmune disease treat... | Trinity College’s new spin-out organisation, Azadyne, has completed a £1.5million funding round for ... |
| 04.03.2019 | Dolly the Sheep pioneer on brink of cancer treatment breakth... | IT HAS been a professional crusade against deadly illness – and the scourge of cancer in particular ... |
| 14.02.2019 | TC BioPharm creates allogeneic cell banks for CAR-T cancer t... | – The first completed bio-banks will be used to develop more cost-effective, safe and efficacious ca... |
| 09.05.2018 | How bereaved parents became ‘accidental world leaders’ in 3D... | Naveed and Samiya Parvez built a business so that other families wouldn’t have to suffer what they d... |
| 08.03.2018 | New £50m venture capital fund will give a shot in the arm to... | A brand new £50m venture capital fund launches today with a plan to invest in the UK’s flourishing l... |
| 08.03.2018 | New £50m venture capital fund will give a shot in the arm to... | A brand new £50m venture capital fund launches today with a plan to invest in the UK’s flourishing l... |
| 08.02.2018 | Scotland’s TCB inks CAR-T deal with Japan’s NIPRO | Scotland’s TC Biopharm (TCB) has secured a major investment from Japan with a deal centered on devel... |
| 21.12.2017 | Acerus Enters into a Licensing Agreement with Viramal to Com... | Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has... |
| 12.12.2017 | bluebird bio and TC BioPharm Announce Strategic Collaboratio... | – Deal combines TC BioPharm’s leading gamma delta T Cell capabilities with bluebird’s proven experti... |
| 14.11.2017 | Age of Discovery (PharmaTimes, November 2017) |
Five years on from Pfizer selling Discovery Park, the site’s current chief executive Toby Hunter t... |
| 21.03.2017 | NCL Innovation Leads Second Round of investment in Coomtech ... | Helping to secure market access for this energy company’s pioneering drying process.
NCL Innovation... |
| 16.03.2017 | FutureNova FlipPad – Media Coverage in March 2017 | Following the news of the first US sales of FutureNova Ltd’s FlipPad® sterile iPad® case, the produc... |
| 08.03.2017 | NCL Innovation leads equity investment round into ‘game-chan... | NCL Innovation, the UK’s leading early stage technology investor, is leading a funding round for sta... |
| 15.02.2017 | Kent based sterile technology company FutureNova enjoys inte... | FutureNova Ltd, backed by the Kent County Council run EXEK equity fund, has made its first successfu... |
| 07.02.2017 | Discovery Park Technology Fund invests in pioneering clinica... | In February 2016, the technology fund run by NCL Innovation, UK’s leading early stage technology inv... |
